Page last updated: 2024-11-13

phleomycin d1

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phleomycin D1 : A glycopeptide originally isolated from the bacterium Streptomyces verticillus which contains a (4'R)-4',5'-dihydro-2,4'-bi-1,3-thiazole-2',4-diyl moiety with a a 4-guanidylbutylaminocarbonyl group attached to the 4-position of the terminal thiazole ring. Like all phleomycins, phleomycin D1 can form complexes with redox-active metals such as Co, Cu, and Fe. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID71668282
CHEBI ID75046
MeSH IDM0114139

Synonyms (15)

Synonym
phleomycin d1
zeomycin
zeocin
11031-11-1
unii-o0vc1nek5m
zeocine
o0vc1nek5m ,
CHEBI:75046
bleomycinamide, n1-(4-((aminoiminomethyl)amino)butyl)-7,8-dihydro-
n1-(4-((aminoiminomethyl)amino)butyl)-7,8-dihydrobleomycinamide
plm d1
Q969337
HY-111428
DTXSID301336409
PD057665

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" To discriminate protective from adverse action of LE different experimental designs have been used."( Extract of Lillium candidum L. can modulate the genotoxicity of the antibiotic zeocin.
Bryant, P; Chankova, S; Galova, E; Hadjo, L; Jovtchev, G; Kopaskova, M; Miadokova, E; Mucaji, P; Sevcovicova, A; Yankulova, B, 2011
)
0.37
" Whether the toxic activity of ΔCR PrP and the protective activity or wild-type PrP are cell-autonomous, or can be exerted on neighboring cells, is unknown."( The toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cells.
Biasini, E; Bonetto, V; Chiesa, R; Forloni, G; Harris, DA; Massignan, T; Turnbaugh, JA; Veglianese, P, 2012
)
0.38

Dosage Studied

ExcerptRelevanceReference
" In the most suitable plasmid used, the gene dosage was increased 16-fold by a technique that allows exponential multiplication of a DNA fragment."( Genetic engineering of the multicellular green alga Volvox: a modified and multiplied bacterial antibiotic resistance gene as a dominant selectable marker.
Hallmann, A; Rappel, A, 1999
)
0.3
" reinhardtii strain CW15 in a linear dose-response fashion up to 100 microg ml(-1) which marked the beginning of a plateau."( Induction of DNA double-strand breaks by zeocin in Chlamydomonas reinhardtii and the role of increased DNA double-strand breaks rejoining in the formation of an adaptive response.
Bryant, PE; Chankova, SG; Dimitrova, M; Dimova, E, 2007
)
0.34
" High dosage or prolonged cultivation should thus be avoided to minimize the contamination."( DNA fragmentation caused by an overdose of Zeocin.
Miyazaki, K; Tsukuda, M, 2013
)
0.39
" The Zeocin resistance gene was applied as a valuable reporter for mutant P AOX1 promoter activity, and we used an episomal plasmid vector to ensure a constant reporter gene dosage in the yeast host cells."( Combinatorial mutagenesis and selection to understand and improve yeast promoters.
Berg, L; Brautaset, T; Strand, TA; Valla, S, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
antifungal agentAn antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce.
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
chelate-forming peptide
guanidinesAny organonitrogen compound containing a carbamimidamido (guanidino) group. Guanidines have the general structure (R(1)R(2)N)(R(3)R(4)N)C=N-R(5) and are related structurally to amidines and ureas.
disaccharide derivativeA carbohydrate derivative that is formally obtained from a disaccharide.
bi-1,3-thiazole
glycopeptideAny carbohydrate derivative that consists of glycan moieties covalently attached to the side chains of the amino acid residues that constitute the peptide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (123)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.81)18.7374
1990's8 (6.50)18.2507
2000's44 (35.77)29.6817
2010's63 (51.22)24.3611
2020's7 (5.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.45 (24.57)
Research Supply Index4.82 (2.92)
Research Growth Index5.68 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.81%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other122 (99.19%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]